Mucolytic therapy of acute exacerbations of chronic rhinosinusitis

Abstract

Epidemiologically acute and chronic inflammatory diseases of the mucous membranes of the nose and paranasal sinuses (PNS) are among the most common pathologies. Sinusitis is one of the most common reasons for seeking doctor's aid in developed countries. Patients with rhinosinusitis account for 15 to 36% of all hospitalized patients in ENT units [1, 2]. Rhinosinusitis accounts for an even greater percentage of all respiratory diseases in outpatient settings.